Start for free
Start for free
F

First

Europe, Noord-Holland, The Netherlands, Naarden

Description

First is a pre-seed fund that finances pioneering scientists in The Netherlands active in the emerging fields of regenerative medicine.

Investor Profile

First has made 4 investments, with 2 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (75%)
  • Series A (25%)

Country Focus

  • The Netherlands (75%)
  • United States (25%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Pharmaceutical
  • Medical
  • Genetics
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does First frequently co-invest with?

Curie Capital
Curie Capital
North America, Missouri, United States, Netherlands
Co-Investments: 2
L
LEH
Europe, Zuid-Holland, The Netherlands, Leiden
Co-Investments: 1
DE
Delft Enterprises
Europe, Zuid-Holland, The Netherlands, Delft
Co-Investments: 1
Graduate Entrepreneur Fund
Graduate Entrepreneur Fund
Europe, Zuid-Holland, The Netherlands, Rotterdam
Co-Investments: 1
Fund+
Fund+
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1
Utrecht Health Seed Fund
Utrecht Health Seed Fund
Europe, Utrecht, The Netherlands, Utrecht
Co-Investments: 3
Andera Partners
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Hadean Ventures
Hadean Ventures
Europe, Oslo, Norway, Oslo
Co-Investments: 1
Inkef
Inkef
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
Sunstone Life Science Ventures
Sunstone Life Science Ventures
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 1

What are some of recent deals done by First?

Phlox Therapeutics

Naarden, Noord-Holland, The Netherlands

Phlox Therapeutics specializes in the development of gene therapy to alleviate and cure cardiomyopathies.

BiotechnologyGeneticsMedicalTherapeutics
SeedNov 6, 2024
Amount Raised: $2,038,979
XS Innovations

South Holland, Illinois, United States

XS Innovations is developing vascular access devices to improving quality of life for millions patients.

Health CareMedical
SeedSep 12, 2024
Amount Raised: $1,218,696
TargED Biopharmaceuticals

Utrecht, Utrecht, The Netherlands

TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.

BiopharmaBiotechnologyHealth CarePharmaceutical
Series AFeb 19, 2022
Amount Raised: $44,156,009
TargED Biopharmaceuticals

Utrecht, Utrecht, The Netherlands

TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.

BiopharmaBiotechnologyHealth CarePharmaceutical
SeedNov 24, 2020
Amount Raised: $1,606,158
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator